Target intelligence / Profile preview

Free radical generating enzymes

Molecular classification
Enzyme, Oxidoreductase
01

Overview

Free radical generating enzymes are a broad functional class of enzymes, including NADPH oxidases (NOX), xanthine oxidase (XO), and myeloperoxidase (MPO), that facilitate the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) (Sies & Jones, 2020). These enzymes play vital roles in physiological processes such as the "respiratory burst" in phagocytes for pathogen destruction and the regulation of vascular tone and cellular signaling (Lambeth, 2004). However, their chronic overactivation leads to oxidative stress, which contributes significantly to the pathophysiology of cardiovascular diseases, neurodegeneration, and chronic inflammatory conditions (Forrester et al., 2018). Therapeutic strategies involve using specific inhibitors like allopurinol for XO in the treatment of gout or investigating NOX inhibitors like setanaxib for fibrotic and metabolic diseases (Kallenberg et al., 2022). A major challenge in targeting these enzymes is achieving sufficient selectivity to prevent the suppression of beneficial ROS-dependent immune responses and essential homeostatic signaling pathways (Meijles & Pagano, 2019).

Other names
Pro-oxidant enzymesROS-generating enzymesReactive oxygen species-producing enzymesOxidoreductases
02

Mechanism of action

Inhibition of specific enzymatic pathways (e.g., molybdenum-containing hydroxylases or heme-dependent peroxidases) to decrease the catalytic production of reactive oxygen species (ROS) or reactive nitrogen species (RNS), thereby mitigating oxidative stress-mediated tissue damage (PubMed: 29053303).

03

Biological functions

Redox signalingImmune response (respiratory burst)Pathogen killingCell signalingVascular tone regulationApoptosisOxygen sensing
04

Disease associations

InflammationCardiovascular diseaseCancerNeurodegenerative diseaseDiabetes mellitusIschemia-reperfusion injuryGoutFibrosis
05

Safety considerations

Immunosuppression due to impaired phagocytic respiratory burstInterference with essential redox signaling pathwaysOff-target effects due to structural conservation between enzyme isoformsPotential for increased susceptibility to bacterial and fungal infections
06

Interacting drugs

Allopurinol

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-isoprostane8-hydroxy-2'-deoxyguanosine (8-OHdG)Protein carbonylsNitrotyrosineReactive oxygen species (ROS) levels

Beyond the preview

Go deeper on Free radical generating enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Free radical generating enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call